ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 29.73

Change

-0.61 (-2.01)%

Market Cap

N/A

Volume

2.80K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.26 (+0.77%)

CAD 6.78B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.30B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.17 (+0.60%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.09 (+0.37%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.30 (+0.85%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.47 (+1.03%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.11 (+0.39%)

CAD 3.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 3.55B
PSLV-U:CA Sprott Physical Silver Trust

+0.08 (+0.69%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.07 (+0.31%)

CAD 2.78B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.09% 83% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.09% 83% B 70% C-
Trailing 12 Months  
Capital Gain 1.36% 28% F 31% F
Dividend Return 3.82% 80% B- 68% D+
Total Return 5.18% 36% F 33% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.08% 41% F 39% F
Dividend Return 3.05% 43% F 36% F
Total Return 0.97% 82% B 38% F
Risk Return Profile  
Volatility (Standard Deviation) 4.55% 84% B 93% A
Risk Adjusted Return 67.04% 74% C 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.